FDA Designates MDMA a Breakthrough Therapy for PTSD

9359260414_f5c9c1365d_c-700x467by Heather Callaghan

Is the FDA paving the way to get ecstasy at the doctor’s office?

No, this is not satire. Last week, the Multidisciplinary Association for Psychedelic Studies (MAPSgave a press release stating that the FDA actually granted “Breakthrough Therapy Designation” to MDMA for the treatment of post-traumatic stress disorder (PTSD).

But this is news that many young adult ravers could have informed the government. In case you don’t know, MDMA which stands for methylenedioxymethamphetamine, is the main ingredient in Ecstasy, the popular but illegal drug associated with raves, dancefloors, lights and euphoria.

By granting Breakthrough Therapy Designation, the government is essentially agreeing that this treatment “may have a meaningful advantage and greater compliance over available medications for PTSD” and is fast-tracking it for approval to treat post traumatic stress.



Switch to mobile version
WP Twitter Auto Publish Powered By : XYZScripts.com